1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allarity Therapeutics Inc (ALLR)
  7. Financials

ALLR

Allarity Therapeutics Inc
0.124
0.019 (18.10%)
Upgrade to Real-Time

Allarity Therapeutics Inc. (ALLR) Fundamentals
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
SHARE INFORMATION
Market CapUS$ 3,150,000
Shares Outstanding30,000,000
Float29,853,193
Percent Float99.51%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -2.19
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions19
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months25,408
Institutional Holdings Percent1.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent0.3
Insider Sold Previous 3 Months-
Insider Shares Owned48,904
TRADING INFO
52 Week HighUS$ 3.38
52 Week LowUS$ 0.11
52 Week High ChangeUS$ -94.93
21 Day Moving AverageUS$ 0.1716
21 Day Extended Moving AverageUS$ 0.165559
50 Day Moving AverageUS$ 0.205
50 Day Extended Moving AverageUS$ 0.223527
200 Day Moving AverageUS$ 0.829333
200 Day Extended Moving AverageUS$ 1.2818
10 Day Average Volume716,239
20 Day Average Volume662,587
30 Day Average Volume958,506
50 Day Average Volume2,269,502
Alpha-0.196637
Beta0.1759
Standard Deviation0.341948
R20.001103
7 Day Price ChangeUS$ -0.058
7 Day Percent Change-35.58%
21 Day Price ChangeUS$ -0.0923
21 Day Percent Change-46.78%
30 Day Price ChangeUS$ -0.0782
30 Day Percent Change-42.69%
Month to Date Price ChangeUS$ -0.08
Month to Date Percent Change-43.24%
Quarter to Date Price ChangeUS$ -0.1888
Quarter to Date Percent Change-64.26%
180 Day Price ChangeUS$ -1.15
180 Day Percent Change-91.6%
200 Day Price ChangeUS$ -1.23
200 Day Percent Change-92.11%
Year to Date Price ChangeUS$ -0.1888
Year to Date Percent Change-64.26%

Allarity Therapeutics Inc. (ALLR) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.30
Total Debt To Equity0.80
Int Coverage-77.80
Current Ratio0.40
Leverage Ratio3.70
Quick Ratio0.30
Long Term Debt To Capital0.23
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 6,919,000
Price to Sales0.00
Price to Free Cash-0.20
PE High Last 5 Years0.00
Price To Book2.90
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-0.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-68.61
Return on Equity-247.52
Return on Capital-194.23

Allarity Therapeutics Inc. (ALLR) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorWolf & Company, P.C.
CEOJames G. Cullem
Emplyoees13
Last AuditUE
CIK0001860657
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address210 Broadway
Suite 201
Cambridge, MA
Websitehttps://www.allarity.com
Facsimile-
Telephone+1 401 426-4664
Email-
Your Recent History
NASDAQ
ALLR
Allarity T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230321 02:04:00